When a Subject Can’t Consent Mary A. Banks Director, BUMC IRB January 17, 2007 No man is good enough to govern another man without that other's consent.

Slides:



Advertisements
Similar presentations
Pediatric Research in Maryland: Implications of the Krieger Case
Advertisements

Why is it different? Disease of the mind affecting understanding and mental ability of the human being - disorder of attention concentration cognition.
Confidentiality, Consent and Data Protection Elizabeth M Robertson Deputy Medical Director Grampian University Hospitals Trust.
Protection of Vulnerable Subjects in Research Tracy Rightmer, J.D. Compliance Manager Human Investigation Committee Yale University School of Medicine.
SURROGATE CONSENT LAW: Impact on Research. AB 2328: Surrogate Consent for Research Question: Prior to January 1, 2003, within the state of California,
2005. Why is it necessary When person lacks capacity physicians have power and influence over them which could be abused 30% pts on acute medical wards.
Informed Consent Hemantha Senanayake Chairman, Research Ethics Committee, Faculty of Medicine, University of Colombo.
ETHICS OF CONSENTING IMPAIRED INDIVIDUALS THERAPEUTICS Col Xolani Currie, Nat Dipl Rad, BA, HED, MPH Regulatory Oversight Manager Project Phidisa.
Informed consent requirements
VA Requirements for Vulnerable Subjects Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education.
© HRP Associates, Inc. Informed Consent, Parental Permission & Assent Jeffrey M. Cohen, Ph.D., CIP President, HRP Associates, Inc.
Vulnerable Populations Subpart B Requirement for IRB to make Protocol Specific Determinations.
Conducting Human Research with Vulnerable Populations Michelle Brignac, CIP Human Research Protection Program Manager.
When you can’t manage your own affairs The Protection of Personal and Property Rights Act 1988.
Substitute Decision Making Irina Kordic Murphy Battista LLP.
GUARDIANSHIP IN UTAH Legal Terms and Procedures. HOW DO I KNOW IF MY FAMILY MEMBER NEEDS GUARDIANSHIP? These questions are directly from the Utah Protective.
Pediatric Ethics Subcommittee of Pediatric Advisory Committee, September 10, 2004 Analysis of Research Protocols Involving Children: Combining Subparts.
Subject Selection and Recruitment David Wendler Department of Clinical Bioethics NIH, USA.
Use of Children as Research Subjects What information should be provided for an FP7 ethical review?
IRB 101: Informed Consent Columbia University Medical Center IRB September 22, 2005.
Determining capacity and protecting subjects who have lost capacity Jason Karlawish, MD University of Pennsylvania.
8 Criteria for IRB Approval of Research 45 CFR (a)
1 Consent for treatment A summary guide for health practitioners about obtaining consent for treatment Bridie Woolnough Resolution Officer Health Care.
Human Subject Research Ethics
IRB Discussion Consent and Assent Issues in Vulnerable Populations December
HRPP Training – Session Two Human Research Protection Program Manager
The Goals and Principles of Human Participant Protection Part 4: Vulnerable Populations.
Sara Brand Associate Director Research Compliance Administration.
Research with Vulnerable Populations Marisue Cody, PhD, RN IRB Chair Training Washington DC, April 9, 2004.
Regulatory criteria for approval Bob Craig, July 2007.
© 2008 Wiggin and Dana Studies Involving Individuals with Impaired Capacity: Assessing Capacity to Consent Michelle Wilcox DeBarge, Esq. Wiggin and Dana.
IRB Board Education Session 6 How Consent Regulations are Implemented in INSPIR Mary Banks Director, Office of the IRB June -July 2005.
Planned Emergency Research Exception from Informed Consent Requirements September 2007.
1 Support needs of guardians and attorneys in Scotland Jan Killeen, Public Policy Director, Alzheimer Scotland.
West Virginia University Office of Research Integrity & Compliance Human Research Protections Program.
THE MENTAL CAPACITY ACT WHY THE ACT? No existing legal framework to protect incapacitated people Only safeguards relate to money & assets Incapacity.
Informed Consent in the Cognitively Impaired Ann Marie Hake, M.D. Associate Professor Of Clinical Neurology Indiana University School of Medicine.
1 Protection of Vulnerable Subjects in Research Melody Lin, Ph.D. December 2012.
IRB BASICS: Issues in Ethics and Human Subject Protections Prepared by Ed Merrill Department of Psychology November 12, 2009.
Institutional Review Board (IRB) What is our Purpose and Role for Ethical Research.
INFORMED CONSENT The Ethical Principle The Regulations The Document The Process What Should It All Mean To Me?
TUN IRB: The Basics February 26, IRB Function Review human-subject research Ensure the rights & welfare of human subjects are adequately protected.
Consent & Vulnerable Adults Aim: To provide an opportunity for Primary Care Staff to explore issues related to consent & vulnerable adults.
Case Studies: Puzzles in Human Research Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst, Program for Research Integrity Development and Education.
Legal Aspects of Nursing Part 1
Regulatory requirements: children, assent, and consent waivers and waiver of documentation Bob Craig, 2007.
By MUREREREHE Julienne BDT(Hons) KHI..  Informed consent is a legal document, prepared as an agreement for treatment, non-treatment, or for an invasive.
Pediatric Research Ethics and the Research Subject Advocate Tomas Jose Silber, MD, MASS RSA and Director, Office of Ethics, CNMC Professor of Pediatrics,
Medical Research in Times of Bioterrorism - OHRP’s Perspective Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Ethics in Research Each research study involves a careful risk/benefit analysis prior to beginning data collection. The question each researcher must ask.
Informed Consent It’s a Process …not a form. Outline  Historical Background  Respect for Persons  Consent Process  Elements of Informed Consent 
Back to Basics – Approval Criteria
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Children in Research: They’re Not Just Small Adults
Research on Populations Prone to Being Vulnerable
Risk Determinations and Research with Children
Annette Prince JD, MA Bioethics, LCSW
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Overview of Important Changes to the Final Rule
How the Regulations Protect Potentially Vulnerable Subjects in Research (With Reference to the Revised Common Rule) Julia Gorey, J.D. October 30, 2018.
Research with Adults with Diminished Capacity to Provide Consent
Overview of Important Changes to the Final Rule
Appendix 2 of New Application
Revised Common Rule: Informed Consent Changes
Ethical Considerations for Pediatric Clinical Investigations
Additional Protections for Children Involved as Subjects in Research
Office of Research Integrity and Protections
Obtaining Proof of Decision-Making Authority
Informed Consent Allison Blodgett, PhD, CIP Director of IRB Operations
Presentation transcript:

When a Subject Can’t Consent Mary A. Banks Director, BUMC IRB January 17, 2007 No man is good enough to govern another man without that other's consent. ~ Abraham Lincoln

Informed Consent Informed Consent Fundamental principle of ethical research Fundamental principle of ethical research Self-determination Self-determination Autonomous choice Autonomous choice Informed and voluntary Informed and voluntary Subject understands Subject understands –the nature of the research –the consequences of participation –the alternatives (including the alternative to not participate –that the research interventions are research and may not have a therapeutic benefit 45 CFR & 21 CFR 50.20

What if Obtaining Consent is Not Possible? Non-exempt research Non-exempt research Not FDA research (except emergency) Not FDA research (except emergency) Studies where subjects are unavailable (i.e. retrospective chart review) Studies where subjects are unavailable (i.e. retrospective chart review) Waiver of Informed Consent (J4 INSPIR) Waiver of Informed Consent (J4 INSPIR) –No more than minimal risk –Waiver does not adversely impact subjects’ rights or welfare –Research cannot practicably be carried out without the waiver –Subjects provided with additional pertinent information after participation (as applicable) 45 CFR

When Some or All Subjects Cannot Give Consent Subjects are or might not be competent to give voluntary informed consent for research Subjects are or might not be competent to give voluntary informed consent for research Children Children Cognitively or Decisionally Impaired Adults Cognitively or Decisionally Impaired Adults –Comatose –Alzheimer’s Disease (moderate to advanced) –Mentally retardation –Psychiatric Illness

Is it Ethical to Proceed When Subject Can’t Consent? Some say no Some say no Others say it is ethically acceptable to proceed with research on these VULNERABLE SUBJECTS under certain circumstances Others say it is ethically acceptable to proceed with research on these VULNERABLE SUBJECTS under certain circumstances IRBs are required to include additional safeguards IRBs are required to include additional safeguards –To protect the rights and welfare of vulnerable subjects –Minimize risk of harm and discomfort –Minimize risk of exploitation

Two “Additional Protections” Consideration of the risk level of the study Consideration of the risk level of the study –Using OHRP’s definition of harm or discomfort –Minimize risk of harm or discomfort to subjects –Take into account the potential for direct benefit to the subject –What is the socially acceptable risk to accept (for someone else) if there is not potential for direct benefit Consideration as to whether it is scientifically necessary to enroll decisionally impaired to answer the study question Consideration as to whether it is scientifically necessary to enroll decisionally impaired to answer the study question –“necessity requirement” –Minimize exploitation

Plan to Assess Capacity to Consent Is there evidence that the subject can Is there evidence that the subject can –make a reasoned choice –understand the research, the risks, the alternatives If subject has capacity – he/she should consent If subject has capacity – he/she should consent Assessment is made by person obtaining consent Assessment is made by person obtaining consent Some studies have specific tools / processes Some studies have specific tools / processes –MacArthur Competence Assessment Tool –Answer 4 questions after explaining consent BUMC IRB - no universal requirement BUMC IRB - no universal requirement If likely subjects will be /become decisionally impaired – assessment plan may be required If likely subjects will be /become decisionally impaired – assessment plan may be required Don’t forget ongoing assessment of capacity Don’t forget ongoing assessment of capacity

When Adult Subject Can’t Consent Designated Proxy Consent Designated Research Proxy –Designated by advanced directive –Designated by the subject when subject still had/has capacity –Can be anyone the subject decides (does not have to be a relative) –This is a selected decision maker –Must be specified to make research decisions –By substituted judgment (what the subject would want) or in the best interest of the subject –Person may limit the authority of their research proxy (i.e. minimal risk studies only, cancer studies only) –Sample form- will post on IRB website –Not the same as a financial POA or healthcare proxy

LAR (Next of Kin) Not specifically designated by subject to make research decisions Not specifically designated by subject to make research decisions Subject didn’t assign a proxy before he/she lost capacity Subject didn’t assign a proxy before he/she lost capacity Restricted to family members and legal guardians Restricted to family members and legal guardians Assumption that family in best position to know what the subject would want (substituted judgment) or decide in subject’s best interest Assumption that family in best position to know what the subject would want (substituted judgment) or decide in subject’s best interest “An individual or judicial or other body authorized under applicable law to consent on behalf of a prospective subject to the subject’s participation in the procedure(s) involved in research “ 45 CFR46.102©; 21CFR50.3(k) “An individual or judicial or other body authorized under applicable law to consent on behalf of a prospective subject to the subject’s participation in the procedure(s) involved in research “ 45 CFR46.102©; 21CFR50.3(k) Sequence of kinship: spouse, adult child, parent, sibling… Sequence of kinship: spouse, adult child, parent, sibling… LAR consent from spouse obtained whenever possible; if incapable or can’t be reached in a reasonable time, document and move down the line of kinship LAR consent from spouse obtained whenever possible; if incapable or can’t be reached in a reasonable time, document and move down the line of kinship

Legally Authorized Representative: an individual or judicial or other body authorized under applicable law to consent on behalf of a prospective subject to the subject's participation in the procedure(s) involved in the research 45 CFR § (c); 21 CFR 50.3(k) Representative TypeGranting AuthorityResearch Type General Health Care Proxy Competent IndividualProcedures/interventions having prospect of direct benefit to individual Research Specific ProxyCompetent IndividualAs specified by proxy General Agent designated by Power of Attorney Competent IndividualIf allowed under terms of POA designation Next-of-KinCommon LawProcedures/interventions having prospect of direct benefit to individual Next-of-Kin/Guardian Assent Common LawNon-beneficial procedures/interven tions< minimal risk when 45 CFR (d) criteria met (No waiver for FDA-covered research) GuardianCourt AppointedProcedures that are not extraordinary and meet the substituted judgment standard*or are in best interest of ward Guardian With Special Authority Court AppointedAs specified by decree LEGALLY AUTHORIZED

Studies involving Study Partners Study partner is not the same as a research proxy or LAR Study partner is not the same as a research proxy or LAR Study partner may participate in the study by assisting subject with taking meds, keeping diaries, attending appointments Study partner may participate in the study by assisting subject with taking meds, keeping diaries, attending appointments Study partner may or may not be a study subject Study partner may or may not be a study subject Study partner may sign an agreement (not ICF) Study partner may sign an agreement (not ICF) Study partner GIVES CONSENT only if Study partner GIVES CONSENT only if –Subject cannot provide consent AND –Subject has designated this person as research proxy –This person meets qualifications as LAR

Consent for Children Subpart D of the OHRP regulations Subpart D of the OHRP regulations Parents provide consent (permission)- IRB determines if one or two parents necessary Parents provide consent (permission)- IRB determines if one or two parents necessary Child provides assent (if required by the IRB) Child provides assent (if required by the IRB) Only the parent or a legal guardian can consent for the child Only the parent or a legal guardian can consent for the child “next of kin” rules do NOT apply “next of kin” rules do NOT apply Children who are “wards of the state” cannot be enrolled without specific IRB permission Children who are “wards of the state” cannot be enrolled without specific IRB permission

Other Consent Issues Consent from Prisoners Consent from Prisoners Consent for neonates, fetuses, etc. Consent for neonates, fetuses, etc. Vulnerable Subjects Vulnerable Subjects Additional Protections under the regulations Additional Protections under the regulations IRB specific findings for studies involving children, pregnant women, neonates, fetuses, and prisoners IRB specific findings for studies involving children, pregnant women, neonates, fetuses, and prisoners

Yes No, but may become impaired during the research A. Obtain informed consent for research from subject B. Have subject identify a research specific proxy to give consent in the future YesMEETS THE REQUIREMENTS FOR CONSENT No Is the study greater than minimal risk (determined by IRB ) – Section E of INSPIR No Yes Can IRB grant waiver of consent (Section J4)? ** IRB can’t waive consent for FDA research except under emergency waiver Yes NO Redesign the study to use a different cohort or exclude decisionally impaired subjects Is the subject DECISIONALLY IMPAIRED? yesNO Is there prospect of direct benefit to individual subjects? (Sections E and I of INSPIR) yes Enrollment of decisionally impaired subject NOT ALLOWED with LAR consent Is there NEXT OF KIN available /willing to provide consent? No Yes Consent may be obtained from this LAR (legally authorized representative) ***Provisions should be made for consenting SUBJECTS if there is a potential for them to become able to consent for themselves in the future No ****Dissent is ALWAYS honored Subject identified a research proxy (when he WAS competent) & Proxy will consent Is it necessary to do this study on this subject /cohort of subjects to answer the study question? No Yes Is there NEXT OF KIN available /willing to provide consent? Yes Is it necessary to do this study on this subject /cohort of subjects to answer the study question? Enrollment of decisionally impaired subject can’t be done NO

Example #1 Study of how comatose adult subjects in ICU respond to certain stimuli Study of how comatose adult subjects in ICU respond to certain stimuli Minimal risk stimuli like lights, music, voices, etc. Minimal risk stimuli like lights, music, voices, etc. It is expected that subjects will not have designated research proxies It is expected that subjects will not have designated research proxies Is LAR possible? Is LAR possible? If so, who can consent for subjects? If so, who can consent for subjects?

Example #2 Study of patients with severe dementia to obtain CSF samples (by spinal tap) for future research Study of patients with severe dementia to obtain CSF samples (by spinal tap) for future research Subjects were previously enrolled in another study so some subjects appointed research proxies Subjects were previously enrolled in another study so some subjects appointed research proxies Who (if anyone) can consent for these subjects to participate Who (if anyone) can consent for these subjects to participate –Subject ? –Designated research proxy ? –Family member ?

Example #3 Study of moderately mentally retarded adults living on their own and working in the community Study of moderately mentally retarded adults living on their own and working in the community Study is a survey of how they spend their money Study is a survey of how they spend their money Who can consent? Who can consent? If it is determined that they do not have the capacity to consent can they appoint a research proxy? If it is determined that they do not have the capacity to consent can they appoint a research proxy?

Example #4 Study of subjects with early, mild dementia Study of subjects with early, mild dementia Study involves survey and annual blood draw of 10cc for future research use Study involves survey and annual blood draw of 10cc for future research use Can subject appoint a research proxy at this time? Can subject appoint a research proxy at this time? Who can consent Who can consent –Subject? –Research proxy? –LAR?

More Information If the Subject Can't Consent, Then What? If the Subject Can't Consent, Then What? –Oct CR Times, Mary Banks Clinical Research Without Informed Consent: How Can it be Legal? How Can it be Ethical? Clinical Research Without Informed Consent: How Can it be Legal? How Can it be Ethical? –1/31/05 Susan Fish, PharmD, MPH Problems of Informed Consent and Low Literate Populations Problems of Informed Consent and Low Literate Populations –June, 2006 Issue Michael K. Paasche-Orlow, MD, MPH